Treatment of Kaposi sarcoma-associated herpesvirus (KSHV)-associated cancers
Kaposi sarcoma (KS) is the most frequent AIDS-defining cancer worldwide. Kaposi sarcoma associated herpesvirus (KSHV) is the etiological agent of KS, and the virus is also associated with two lymphoproliferative diseases. Both KS and KSHV-associated lymphomas, are cancers of unique molecular compos...
Main Authors: | Dirk P Dittmer, Kristy L Richards, Blossom eDamania |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-04-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2012.00141/full |
Similar Items
-
Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) – review
by: Iftode Nicoleta, et al.
Published: (2020-12-01) -
Kaposi's sarcoma-associated herpesvirus at 27
by: Marta Maria Gaglia
Published: (2021-12-01) -
Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
by: Aude Jary, et al.
Published: (2021-12-01) -
Kaposi's sarcoma associated herpesvirus (KSHV) entry into target cells
by: Sayan eChakraborty, et al.
Published: (2012-01-01) -
Lytic Reactivation of the Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations
by: Nofar Atari, et al.
Published: (2022-08-01)